Santosh Adhikari
About Santosh Adhikari
Santosh Adhikari is a Principal Scientist in Cheminformatics at BenevolentAI, with a background in organic synthesis, computational chemistry, and cheminformatics.
Company
Santosh Adhikari currently holds the position of Principal Scientist, Cheminformatics at BenevolentAI. This role involves leveraging advanced computational techniques to enhance drug discovery processes. BenevolentAI is known for its commitment to utilizing artificial intelligence to accelerate the development of new medicines, making it a significant player in the biotech and pharmaceutical industries.
Title
As a Principal Scientist in Cheminformatics, Santosh Adhikari brings a wealth of expertise in computational methods to enhance drug discovery. His responsibilities likely include the integration of informatics technologies with traditional medicinal chemistry approaches, optimizing workflows to streamline the identification and validation of new drug candidates.
Previous Roles at AstraZeneca
Before joining BenevolentAI, Santosh Adhikari served as a Senior Research Scientist at AstraZeneca for three years, from 2021 to 2024, in Cambridge, England, United Kingdom. In this capacity, he was involved in cutting-edge research and development efforts within one of the world's leading pharmaceutical companies. His work presumably focused on enhancing drug discovery and development through the application of cheminformatics and computational chemistry.
Postdoctoral Research at University of Cambridge
From 2016 to 2021, Santosh Adhikari was a Postdoctoral Research Associate at the University of Cambridge. During his five years at this prestigious institution, he likely engaged in significant research projects, advancing his expertise in the integration of organic synthesis with computational chemistry techniques. His tenure at Cambridge would have provided a solid foundation in both theoretical and practical aspects of cheminformatics.
Education and Expertise: Newcastle University
Santosh Adhikari completed his PhD in Chemistry, specializing in Medicinal and Pharmaceutical Chemistry, at Newcastle University from 2012 to 2016. Prior to this, he achieved an MSc in Drug Chemistry from the same institution in 2011-2012. His educational background provided a strong foundation in both organic synthesis and computational approaches to drug discovery. His multifaceted skill set spans organic synthesis, computational chemistry, and biological assay validation, making him a versatile scientist in the field.